European VitreoRetinal Society a certain philosophy

                  Introduction: To describe the case of an atypical Persistent Subretinal Fluid presentation following a macula ON R.D. Results: A 64 y.o woman developed a Macula ON retinal detachment extending from 5 to 11 o’clock, with a unique retinal break at 10 o’clock but threatening the Macular area. For such reason, a vitrectomy was realised to drain the subretinal fluid...

Advantages: To describe the effect of intravitreal ranibizumab for the treatment of choroidal neovascularisation and macular edema secondary to Best’s vitelliform macular dystrophy. Methods: A 38-year-old Asian woman with confirmed Best’s disease presented with decreased visual acuity (VA) due to secondary choroidal neovascularisation and macular edema. She was treated with a single intravitreal injection of ranibizumab (Lucentis, 0.5...

Purpose:   Review of the management of choroidal neovascularisation secondary to Best’s vitelliform macular dystrophy. Materials and methods: Eight eyes of 6 patients with Best’s disease complicated by choroidal neovascularization (CNV) were included. The visual acuity, angiographic and optical coherence tomography (OCT) findings were used to assess management outcome.  All patients presented with reduction in visual acuity.  Two...

Naomi S. Falk, MD (Albany, NY), Paul M. Beer, MD (Albany, NY), Amjad M. Hammad, MD (Albany, NY) PURPOSE: To explore contrast between objective improvement and visual function. METHODS: Study design is a case report of a 55 year old woman who received 2 injections of intravitreal Bevacizumab for Adult Vitelliform dystrophy due to complaints of blurred vision and distortion. She had received 4 prior injections of Pegaptanib sodium without...